☆ 4.5 Article

Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion

HEPATOLOGY RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Review Gastroenterology & Hepatology

Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise

Amit Kumar Singh et al.

Summary: Liver cancer is a major public health concern with increasing clinical cases and a 5-year survival rate of 30%-35% after diagnosis. Hepatocellular carcinoma (HCC) is the primary subtype and accounts for approximately 75% of liver cancer cases. Treatment options depend on the stage of progression and include surgery, ablation, radiotherapy, drugs, and immunotherapy. Various metabolic and signaling pathways, as well as dysbiosis, play important roles in HCC progression. Drug-induced toxicity is a challenge, leading to the search for effective and safe medications such as natural compounds. This review summarizes the current research, treatment strategies, and chemopreventive role of natural products in managing liver cancer.

WORLD JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Oncology

A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection

Huanhuan Wang et al.

Summary: This study aimed to identify risk factors for early recurrence and develop a predictive model for early recurrence in HCC patients. The study found that elevated levels of AFP and VEGF-A, microvascular invasion, intratumor necrosis, and surgical margin were independent risk factors for early recurrence. A model incorporating blood biomarkers and pathological variables achieved good predictive performance for early recurrence in HCC patients.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Oncology

TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2

Zheng Guo et al.

Summary: Colorectal cancer is a common cancer with limited treatment strategies. This study shows that TELO2 is significantly upregulated in CRC, and its inhibition can restrain cell growth, cell cycle, and metastasis. TELO2 overexpression is positively correlated with age, lymph node metastasis, and TNM stage in CRC patients.

ONCOLOGY REPORTS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation

Jiarui Yang et al.

Summary: A nomogram was established to predict the risk of microvascular invasion in hepatocellular carcinoma (HCC) preoperatively, which showed good discrimination, calibration, and effectiveness in internal validation. The predictive model demonstrated specificity of 80.7% and sensitivity of 58.7% at a cut-off value of 0.312, providing valuable guidance for treatment planning.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B

Jianbo Xu et al.

CANCER LETTERS (2020)

Add to Collection

Article Oncology

Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors

Mohamed E. Salem et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection

Review Gastroenterology & Hepatology

Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis

Zhen-Hua Chen et al.

HPB (2019)

Add to Collection

Article Cell Biology

Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63

Hu-Cheng Liu et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Add to Collection

Article Medicine, Research & Experimental

Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme

Yaodong Chen et al.

THERANOSTICS (2019)

Add to Collection

Article Genetics & Heredity

Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression

Ujani Chakraborty et al.

GENETICS (2018)

Add to Collection

Article Genetics & Heredity

Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression

Ujani Chakraborty et al.

GENETICS (2018)

Add to Collection

Article Oncology

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

Waldemar Wilczak et al.

CARCINOGENESIS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Add to Collection

Article Pathology

Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness

Hanako Tsujikawa et al.

HUMAN PATHOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation

Arisa Kumagai et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2016)

Add to Collection

Article Oncology

Overexpression of hMSH2 and hMLH1 protein in certain gastric cancers and their surrounding mucosae

Mei Li et al.

ONCOLOGY REPORTS (2014)

Add to Collection

Article Oncology

Molecular and clinical characteristics of MSH6 germline variants detected in colorectal cancer patients

Hiroko Terui et al.

ONCOLOGY REPORTS (2013)

Add to Collection

Editorial Material Oncology

The Human Protein Atlas - a tool for pathology

F. Ponten et al.

JOURNAL OF PATHOLOGY (2008)

Add to Collection

Article Oncology

Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance

Shannon L. Gibson et al.

CANCER LETTERS (2006)

Add to Collection

Article Gastroenterology & Hepatology

Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China

Shu-Hui Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)

Add to Collection

Article Oncology

Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers

F Chiappini et al.

CARCINOGENESIS (2004)

Add to Collection

Article Biotechnology & Applied Microbiology

Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT mutation database

P Peltomaki et al.

DISEASE MARKERS (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.